Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

LON/0W1Q stock hub

LON/0W1Q has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0W1Qis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

77.7M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0W1Q

In the news

Latest news · LON/0W1Q

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-43.4

P25 -54.2P50 2.1P75 13.7

ROIC-6.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0W1Q market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

EUR

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	UK
Employees	2
Employees Change	1%
Employees Change Percent	100
Enterprise value	EUR 85.5M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	DE000A289V03
Last refreshed	2026-05-10
Market cap	EUR 77.7M
Price	EUR 21.7
Price currency	EUR
Rev Per Employee	-5,730,424x
Sector	Healthcare
Sic	2834
Symbol	lon/0W1Q
Website	https://www.mph-ag.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-127.19%
EV Earnings	-0.87x
EV/FCF	26.69x
FCF yield	4.12%
P/B ratio	0.44x
P/S ratio	-6.78x
PE Ratio3 Y	1.62x
PE Ratio5 Y	1.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -11.5M
Gross Profit Growth Q	-93.52%
Net Income	EUR -98.8M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	870.83%
Profit Per Employee	EUR -49.4M
Profitable Years	4
ROA	-3.26
Roa5y	7.14
ROCE	-6.92
ROE	-43.43
Roe5y	0.88
ROIC	-6.85
Roic5y	11.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-5.66%
Cagr3y	20.06%
Div CAGR3	0.94%
Div CAGR5	-10.36%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth5 Y	297.28%
Revenue Growth	89.76x
Revenue Growth Q	-93.52x
Revenue Growth Quarters	1x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 187.6M
Cash	EUR 2.3M
Current Assets	EUR 2.4M
Current Liabilities	EUR 5.9M
Debt	EUR 10M
Debt Equity	EUR 0.06
Debt FCF	EUR 3.14
Equity	EUR 175.8M
Interest Coverage	-21.29
Liabilities	EUR 11.8M
Long Term Assets	EUR 185.2M
Long Term Liabilities	EUR 5.8M
Net Cash	EUR -7.8M
Net Cash By Market Cap	EUR -10.01
Net Debt Equity	EUR 0.04
Net Debt FCF	EUR 2.43
Tangible Book Value	EUR 175.8M
Tangible Book Value Per Share	EUR 41.07
WACC	9.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.4
Net Working Capital	EUR -63,294
Quick ratio	0.39
Working Capital	EUR -3.5M
Working Capital Turnover	EUR 12.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	2.84%
Dividend Growth Years	1%
Dividend per share	EUR 1.04
Dividend Years	2
Dividend Yield	4.79%
Ex Div Date	2025-07-18
Last Dividend	EUR 1.04

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-5.65%
200-day SMA	20.77
3Y total return	73.1%
50-day SMA	21.49
50-day SMA vs 200-day SMA	50over200
All Time High	29.2
All Time High Change	-25.68%
All Time High Date	2025-12-11
All Time Low	14
All Time Low Change	55%
All Time Low Date	2023-03-31
ATR	0.75
Beta	0.99
High	21.7
High52	29.2
High52 Date	2025-12-11
High52ch	-25.68%
Low	21.7
Low52	15.5
Low52 Date	2026-03-25
Low52ch	40%
Ma50ch	1%
Price vs 200-day SMA	4.5%
RSI	57.82
RSI Monthly	53.8
RSI Weekly	52.18
Sharpe ratio	0.38x
Sortino ratio	0.63
Total Return	4.79%
Tr1m	14.21%
Tr1w	1.4%
Tr3m	-6.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -12.6M
Operating Income Growth Q	-94.19
Operating margin	109.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-1,456,878.6
Shares Institutions	0.56%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 3.2M
Average Volume	51.25x
Bv Per Share	41.07
CAPEX	EUR -3,556
Ch1m	14.21
Ch1w	1.4
Ch1y	-11.43
Ch3m	-6.06
Ch3y	55
Ch6m	23.65
Change	2.36%
Change From Open	0
Close	21.2
Days Gap	2.36
Depreciation Amortization	38,910.9
Earnings Date	2026-05-27
EBIT	EUR -12.6M
EBITDA	EUR -12.5M
EPS	EUR -23.07
F Score	2
FCF	EUR 3.2M
FCF EV Yield	3.75x
Financing CF	-6,377,710
Fiscal Year End	December
Founded	2,008
Income Tax	EUR -1M
Investing CF	3,659,419
Is Primary Listing	0
Last Earnings Date	2025-11-20
Last Report Date	2025-06-30
Last Split Date	2020-09-22
Last Split Type	Reverse
Ma150	20.38
Ma150ch	6.5%
Ma20	19.79
Ma20ch	9.64%
Net CF	-409,941
Next Earnings Date	2026-05-27
Open	21.7
P FCF Ratio	24.25
P OCF Ratio	24.22
Payment Date	2025-07-22
Ppne	91,715.8
Price Date	2026-05-08
Ptbv Ratio	0.44
Relative Volume	0.04x
Revenue	-11,460,848x
Tr6m	23.65%
Z Score	5.01

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0W1Q dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.8%

$1.04 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-10.4%

1 consecutive years of growth

Total shareholder yield

+4.8%

Next ex-dividend date: 2025-07-18

Performance

LON/0W1Q stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0W1Q?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0W1Q momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.8

Neutral momentum band

Price vs 200-day MA

+4.5%

50/200-day relationship not available

Beta (5Y)

0.99

Moves roughly with the market

Sharpe ratio

0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0W1Q

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0W1Q stock rating?

lon/0W1Q is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0W1Q analysis?

The full report lives at /stocks/lon/0W1Q/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0W1Q?

The latest report frames lon/0W1Q around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0W1Q page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.